Sei Investments Co. boosted its position in HealthSouth Corporation (NYSE:HLS) by 25.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,670 shares of the company’s stock after buying an additional 36,718 shares during the period. Sei Investments Co. owned approximately 0.20% of HealthSouth Corporation worth $8,842,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Neuburgh Advisers LLC increased its position in HealthSouth Corporation by 40.1% in the first quarter. Neuburgh Advisers LLC now owns 3,072 shares of the company’s stock worth $132,000 after buying an additional 880 shares in the last quarter. Glen Harbor Capital Management LLC increased its position in HealthSouth Corporation by 40.1% in the first quarter. Glen Harbor Capital Management LLC now owns 4,224 shares of the company’s stock worth $181,000 after buying an additional 1,210 shares in the last quarter. BB&T Corp purchased a new position in HealthSouth Corporation during the first quarter worth approximately $200,000. Elkfork Partners LLC increased its position in HealthSouth Corporation by 40.1% in the first quarter. Elkfork Partners LLC now owns 5,376 shares of the company’s stock worth $230,000 after buying an additional 1,540 shares in the last quarter. Finally, Fox Run Management L.L.C. purchased a new position in HealthSouth Corporation during the first quarter worth approximately $231,000. Hedge funds and other institutional investors own 97.96% of the company’s stock.
Shares of HealthSouth Corporation (HLS) opened at 43.82 on Friday. The firm’s 50-day moving average price is $45.57 and its 200-day moving average price is $44.19. The company has a market cap of $4.33 billion, a PE ratio of 15.97 and a beta of 0.61. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71.
HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings results on Monday, July 31st. The company reported $0.71 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.68 by $0.03. The firm had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The business’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.69 EPS. Equities analysts predict that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be given a dividend of $0.25 per share. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.00 annualized dividend and a dividend yield of 2.28%. HealthSouth Corporation’s payout ratio is 35.29%.
A number of equities analysts recently commented on HLS shares. Zacks Investment Research upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $49.00 price objective on the stock in a report on Wednesday, August 2nd. ValuEngine upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating in a report on Friday, July 7th. Royal Bank Of Canada restated a “buy” rating and issued a $53.00 price objective on shares of HealthSouth Corporation in a report on Wednesday, July 5th. BidaskClub upgraded HealthSouth Corporation from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Finally, Piper Jaffray Companies restated a “hold” rating and issued a $50.00 price objective on shares of HealthSouth Corporation in a report on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $48.83.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the transaction, the chief executive officer now owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.